 CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 08, 2022 GLOBE NEWSWIRE -- Acumen Pharmaceuticals, Inc. NASDAQ: ABOS, a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimers disease AD, today announced that the Company will report its financial results for the second quarter 2022 on Monday, August 15, 2022. The company will host a conference call and live audio webcast at 4:30 p.m. ET to provide a business and financial update. 